D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake

Journal of Nuclear Medicine

Volumn 38, Issue 12, 1997, Pages 1929-1933

  Bernard, Bert F ^b   Krenning, Eric P ^b   Breeman, Wout A P ^b   Rolleman, Edgar J ^b   Bakker, Willem H ^b   Visser, Theo J ^b   Mäcke, Helmut ^b   De Jong, Marion ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

D lysine; Indium 111 octreotide; L lysine; Peptide receptor radiotherapy; Renal tubular reuptake; Yttrium 90 octreotide

Indexed keywords

PENTETREOTIDE IN 111; YTTRIUM 90;

ARTICLE; DRUG UPTAKE; INTERMETHOD COMPARISON; KIDNEY SCINTISCANNING; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOACTIVITY;

ANIMALS; INDIUM RADIOISOTOPES; KIDNEY; LYSINE; MALE; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 0031475064     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
2. Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press; 1995:1-50.
3. Krenning EP, Bakker WH, Kooij PP, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med 1992;33:652-658.
4. Krenning EP, Kooij PPM, Pauwels S, et al. Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion 1996;57:57-61.
5. Rowlinson G, Snook D, Stewart S, Epenetos AA. Intravenous EDTA to reduce bone uptake of Y-90 following Y-90 labeled antibody administration. Br J Cancer 1989;59:322.
6. Jowsey J, Rowland RE, Marshall JH. The deposition of the rare earths in bone. Radiation Res 1958;8:490-501.
7. 3]octreotide, a promising somatostatin analog for radionuclide therapy. Eur J Nucl Med 1997;24:368-371.
8. Mogensen CE, Solling K. Studies on renal tubular protein reabsorption: partial and near complete inhibition by certain amino acids. Scan J Clin Lab Invest 1977;37:477-486.
9. Hammond PJ, Wade AF, Gwilliam ME, et al. Amino acid infusion blocks renal tubular uptake of an indium-labeled somatostatin analog. Br J Cancer 1993;67:1437-1439.
10. Pimm MV, Gribben SJ. Prevention of renal tubule reabsorption of radiometal (indium-111) labeled Fab fragment of a monoclonal antibody in mice by systemic administration of lysine. Eur J Nucl Med 1994;21:663-665.
11. 1]-octreotide in vivo. J Nucl Med 1996;23:1361-1366.
12. 1]octreotide. Eur J Nucl Med 1995;22:608-616.
13. Behr TM, Sharkey RM, Juweid ME, et al. Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res 1995;55:3825-3834.
14. Behr TM, Becker WS, Sharkey RM, et al. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion. J Nucl Med 1996;37:829-833.
15. 1]octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabeling and in vitro validation. Life Sci 1991;49:1583-1591.
16. Duncan JR, Welch MJ. Intracellular metabolism of indium-111-DTPA-labeled receptor-targeted proteins. J Nucl Med 1993;34:1728-1738.
17. Gullino P, Winitz M, Birnbaum SM, Clyde Otey M, Cornfield J, Greenstein JP. The toxicity of individual essential amino acids and their diastereomers in rats and the effect on blood-sugar levels. Arch Biochem Biophys 1955;58:253-255.
18. Friedman M. Formation, nutritional value and safety of D-amino acids. In: Friedman M, ed. Nutritional and toxicological consequences of food processing. New York: Plenum Press; 1991:447-481.
19. Stolz B, Smith-Jones PM, Albert R, et al. Somatostatin analogs for somatostatin-receptor-mediated radiotherapy of cancer. Digestion 1996;57:17-21.
20. 3]-octreotide. J Nucl Med 1992;33:652-658.